Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Affron® Saffron to Help Improve Mood, Self-Esteem in Adult Women


      News provided by

      Pharmactive Biotech Products, S.L.U.

      Jun 30, 2026, 07:00 ET

      Share this article

      Share this article


      Clinical trial shows Pharmactive's low-dose saffron extract could help mitigate the interconnected challenges of low-mood, poor sleep, and low self-esteem

      Key Takeaways

      • New clinical trial demonstrates Affron® supports mood, sleep quality, and self-esteem in menopausal and post-menopausal women.
      • Nearly half of the women taking Affron® met the study's responder criteria for improvements in scores on the Depression, Anxiety and Stress Scale – Depression Subscale (DASS-D), almost double the proportion observed with placebo.
      • Affron® is a clinically backed, clean-label saffron extract supported by 12 human studies.

      MADRID, June 30, 2026 /PRNewswire/ -- Results of a new clinical study indicate that Affron®, the natural saffron extract developed by nutraceutical leaders Pharmactive Biotech Products, SLU, demonstrated positive effects on mood, sleep, and self-esteem in menopausal and post-menopausal women. Several previous clinical trials illustrated Affron® saffron's positive impact on mood and sleep quality. However, this is the first study to observe a combined positive effect on these often-intertwined burdens that are prevalent in women who are going through or have recently gone through menopause.

      Continue Reading
      Affron® Saffron to Help Improve Mood, Self-Esteem in Adult Women
      Affron® Saffron to Help Improve Mood, Self-Esteem in Adult Women

      Published in the June 2026 issue of Frontiers in Nutrition, this randomized, double-blind, placebo-controlled trial led by Adrian Lopresti, PhD enrolled 86 women aged 50–70 years experiencing low mood and poor sleep. Participants were randomly assigned to receive either 28 mg of Affron® saffron daily or an identical looking placebo. They completed a series of validated self-report questionnaires before, during, and after the program to evaluate changes in mood, sleep, self-esteem, and physical appearance.

      Nearly twice as many women responded to Affron® compared with placebo

      Following 12 weeks of supplementation, nearly half of the women taking Affron® met the study's responder criteria for improvements in scores on the Depression, Anxiety and Stress Scale – Depression Subscale (DASS-D). This was almost double the proportion of responders observed in the placebo group (25.6%), with improvements beginning to appear after only four weeks. The Affron® group also experienced a 50.7% reduction in low mood scores overall, compared with 31.9% in the placebo group.

      Beyond mood

      Beyond the primary mood outcomes, the study also explored whether Affron® supplementation could influence areas closely connected to emotional well-being, including self-esteem, sleep, and perceived appearance. Self-esteem was assessed using the Rosenberg Self-Esteem Scale, with women taking Affron® showing a 10% improvement compared with 4.8% in the placebo group. As an exploratory outcome, this finding offers an interesting new perspective on the potential broader impact of Affron® supplementation on how women feel about themselves.

      This improvement appeared to be more closely aligned with changes in mood and daily well-being than with changes in physical appearance. Sleep-related outcomes were also assessed using the PROMIS Sleep Disturbance and Sleep-Related Impairment scales.

      "For this study, we focused on menopausal and post-menopausal women, as this is a period associated with increased vulnerability to mood disturbances, impaired sleep, and accelerated facial ageing," informs Adal Mena, R&D Scientist and Product Specialist for Affron "This is the first clinical trial showing that Affron® can positively impact three closely connected aspects of well-being: mood, self-esteem, and the daily impact of poor sleep. The findings reinforce the need for holistic approaches to emotional well-being, and in addition positions Affron® at the intersection of emotional well-being, healthy aging, and beauty-from-within solutions."

      Potential mechanisms underlying the observed effects

      Affron® is a highly concentrated saffron extract, standardized to ≥3.5% Lepticrosalides®, a unique complex of safranal and crocins that supports mood, occasional stress, sleep quality, and emotional balance at a low dose. Its positive influence on mood and sleep quality has been demonstrated in 12 clinical trials, across a broad population, including teenagers. This is the second clinical trial assessing the impact of Affron® on menopausal and post-menopausal women.

      Previous research has linked increased inflammation with lower self-esteem scores in people with obesity and metabolic syndrome. As menopause is also associated with inflammatory and metabolic changes, this could provide a relevant biological context for the self-esteem challenges experienced by some women during this life stage. In this context, the broader emotional well-being benefits observed with Affron® could be partly explained by saffron's complementary mechanisms of action.

      It is suggested that saffron might help influence self-esteem through its documented anti-inflammatory activity, having shown abilities to reduce inflammatory markers. Saffron also has been shown to support neurotransmitter balance by helping modulate serotonin, dopamine, and norepinephrine activity. It increases production of brain-derived neurotrophic factor (BDNF), a regulator of emotional adaptability, and protects brain cells from oxidative stress thanks to its potent antioxidant capabilities.

      "Low mood and poor sleep often go hand in hand, and can negatively impact self-esteem, perceived appearance, skin quality, and overall well-being while also contributing to signs of skin aging," says Carlos Rodríguez, Communication Manager at Pharmactive Biotech Products. "The findings of this study suggest Affron® could support self-esteem through both psychological and physiological pathways. Psychologically, there is a direct link between how we feel and how we perceive ourselves. By effectively reducing low mood and enhancing emotional balance, Affron® might help women feel more confident and positive. On a physical level Affron® may balance key neurotransmitters and lower stress related cortisol levels."

      As Pharmactive's flagship composition, Affron® is a clean-label saffron extract that boasts rapid one-hour absorption and is well-tolerated with no reported significant adverse effects. The proprietary saffron extract has been integrated into a complete range of supplement and food formats, including gummies and chewable formats.

      Company Contact:
      Pharmactive Biotech Products, S.L.U.
      Carlos Rodriguez Iglesias
      Communications Manager
      Tel: +34 635785984
      Email: [email protected]
      Twitter: @Pharmactive_SP
      Web: www.pharmactive.eu

      Press Contact:
      NutriPR
      Liat Simha
      Tel: +972-9-9742893
      E-mail: [email protected]
      Twitter: @NutriPR

      Web: www.nutripr.com

      Photo: https://mma.prnewswire.com/media/3002328/Pharmactive_Affron_Saffron.jpg

      SOURCE Pharmactive Biotech Products, S.L.U.

      Modal title

      Also from this source

      Studies Link Wholefruit Carob Ingredient by Pharmactive to Better Microbiome Balance and Satiety

      Studies Link Wholefruit Carob Ingredient by Pharmactive to Better Microbiome Balance and Satiety

      Two new lab studies displayed potential for the holistic carob-based ingredient Csat®, developed by nutraceutical leaders Pharmactive Biotech...

      Pharmactive Launches Kyoh® for Hair Growth Support

      Pharmactive Launches Kyoh® for Hair Growth Support

      Nutraceutical specialists Pharmactive Biotech Products, S.L.U marks its entry into the beauty-from-within space with the launch of its first...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Pharmaceuticals

      Pharmaceuticals

      Supplementary Medicine

      Supplementary Medicine

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.